Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.
- DOI
- 10.1016/j.clml.2023.09.005
- Published
- 2024 Feb
- Container
- Clinical lymphoma, myeloma & leukemia
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.clml.2023.09.005,
title = {Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.},
author = {Rojek AE and Kline JP and Feinberg N and Appelbaum DE and Pu Y and Derman BA and Jakubowiak A and Kosuri S and Liu H and Nawas MT and Smith SM and Bishop MR and Riedell PA},
year = {2024},
journal = {Clinical lymphoma, myeloma \& leukemia},
doi = {10.1016/j.clml.2023.09.005},
url = {https://doi.org/10.1016/j.clml.2023.09.005}
}RIS
TY - JOUR TI - Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL. AU - Rojek AE AU - Kline JP AU - Feinberg N AU - Appelbaum DE AU - Pu Y AU - Derman BA AU - Jakubowiak A AU - Kosuri S AU - Liu H AU - Nawas MT AU - Smith SM AU - Bishop MR AU - Riedell PA PY - 2024 JO - Clinical lymphoma, myeloma & leukemia DO - 10.1016/j.clml.2023.09.005 UR - https://doi.org/10.1016/j.clml.2023.09.005 ER -
APA
AE, R., JP, K., N, F., DE, A., Y, P., BA, D., A, J., S, K., H, L., MT, N., SM, S., MR, B., & PA, R. (2024). Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.. Clinical lymphoma, myeloma & leukemia. https://doi.org/10.1016/j.clml.2023.09.005
Source records
- pubmed · retrieved 2026-09-25T06:14:38.838Z